Genomix Molecular Diagnostics Private Limited, a active private limited company, was established on 03 January 2007 in Hyderabad, Telangana, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U85110TG2007PTC052224. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.52 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Vijay Kumar Kanthamneni (Director), Rathnagiri Polavarapu (Director), Bilhan Kavikishore Polavarapu (Director). Past directors included Krishnakishore Kota, Bilhan Kavikishore Polavarapu, Ojasvi Polavarapu. It holds ₹2.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No.5-36/207, Prashanth Nagar, Kukatpally, Hyderabad, Telangana, 500072.
U85110TG2007PTC052224
052224
03 January 2007
₹1.00 M
₹0.52 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Genomix Molecular Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Kumar Kanthamneni | Director | 03 Jan 2007 | Current |
| Rathnagiri Polavarapu | Director | 03 Jan 2007 | Current |
| Bilhan Kavikishore Polavarapu | Director | 18 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Director | 28 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genomix Molecular Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.34% decrease. The company also saw a substantial improvement in profitability, with a 79.93% increase in profit. The company's net worth dipped by a decrease of 1.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Genomix Molecular Diagnostics had a public holding of 2.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2009 | Department Of Biotechnology | ₹2.90 M | Open |
Explore comprehensive loan charge details -
Genomix Molecular Diagnostics has a workforce of 7 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genomix Molecular Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Molecular Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Genomix Molecular Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Genomix Molecular Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Bilhan Kavikishore Polavarapu was appointed as a Director was appointed as a Director on 18 Aug 2021 & has been associated with this company since 4 years 4 months . was documented.
The activity A charge with Department Of Biotechnology amounted to Rs. 2.90 M with Charge ID 10175699 was registered on 07 Sep 2009. was completed.
The activity Vijay Kumar Kanthamneni was appointed as a Director was appointed as a Director on 03 Jan 2007 & has been associated with this company since 18 years 11 months . was completed.
The activity Rathnagiri Polavarapu was appointed as a Director was appointed as a Director on 03 Jan 2007 & has been associated with this company since 18 years 11 months . was completed.
The CIN of Genomix Molecular Diagnostics Private Limited is U85110TG2007PTC052224.
Genomix Molecular Diagnostics Private Limited is headquartered at D.No.5-36/207, Prashanth Nagar, Kukatpally, Hyderabad, Telangana, 500072.
Genomix Molecular Diagnostics Private Limited was incorporated on 03 January 2007.
The current directors of Genomix Molecular Diagnostics Private Limited are
The primary industry of Genomix Molecular Diagnostics Private Limited is Professional, Scientific And Technical.
Genomix Molecular Diagnostics Private Limited is unlisted.
The authorized capital of Genomix Molecular Diagnostics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.52 M.
The compliance status of Genomix Molecular Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX